Search

Pages

1. • Journal article

   • 

   A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes

   Demotte, Nathalie[UCL] Bigirimana, René[UCL] Wieers, Grégoire[UCL] Stroobant, Vincent[UCL] Squifflet, Jean-Luc[UCL] Carrasco, Javier[Grand Hopital de Charleroi,UCL] Thielemans, Kris Baurain, Jean-François[UCL] Van Der Smissen, Patrick[UCL] Courtoy, Pierre J.[UCL] van der Bruggen, Pierre[UCL] (2014) Clinical Cancer Research — Vol. 20, no. 7, p. 1823-1833 (2014)
2. • Journal article

   • 

   A Nonapeptide Encoded By Human Gene Mage-1 Is Recognized On Hla-a1 By Cytolytic Lymphocytes-t Directed Against Tumor Antigen-mz2-e

   Traversari, C. van der Bruggen, Pierre[UCL] Luescher, IF. Lurquin, C. Chomez, P. Van Pel, Aline[UCL] De Plaen, Etienne[UCL] Amarcostesec, A. Boon, Thierry[UCL] (1992) The Journal of Experimental Medicine — Vol. 176, no. 5, p. 1453-1457 (1992)
3. • Journal article

   • 

   CD8 T-cell responses against the immunodominant Theileria parvapeptide Tp249-59are composed of two distinct populations specific for overlapping 11-mer and 10-mer epitopes

   Connelley, Timothy K. Li, Xiaoying MacHugh, Niall Colau, Didier Graham, Simon P. van der Bruggen, Pierre[UCL] Taracha, Evans L. Gill, Andy Morrison, William Ivan (2016) Immunology : the journal of cells, molecules, system and technologies — Vol. 149, no.2, p. 172-185 (2016)
4. • Journal article

   • 

   Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation.

   Antonopoulos, Aristotelis Demotte, Nathalie Stroobant, Vincent Haslam, Stuart M van der Bruggen, Pierre[UCL] Dell, Anne (2012) The Journal of biological chemistry — Vol. 287, no.14, p. 11240-51 (2012)
5. • BookChapter

   • 

   Improving the clinical efficacy of cancer vaccines by targeting immune suppression in human tumors

   Demotte, Nathalie[UCL] Antonopoulos, Aristotelis Baurain, Jean-François[UCL] Wieers, Grégoire[UCL] van Baren, Nicolas[UCL] van der Bruggen, Pierre[UCL] (2012) Galectins and Disease Implications for Targeted Therapeutics. Proceedings of the First Symposium on Galectin-Related Therapeutics — [ISBN : 978-0-8412-2880-1]
6. • Journal article

   • 

   Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide

   Bonehill, A Heirman, C. Tuyaerts, Sandra Michiels, A. Zhang, Y. van der Bruggen, Pierre[UCL] Thielemans, K. (2003) Cancer Research — Vol. 63, no. 17, p. 5587-5594 (2003)
7. • Journal article

   • 

   Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

   Gordon-Alonso, Monica[UCL] Hirsch, Thibault[UCL] Wildmann, Claude[UCL] van der Bruggen, Pierre[UCL] (2017) Nature Communications — Vol. 8, p. 793 (2017)
8. • Journal article

   • 

   Temperature-induced Alterations in the Expression of Susceptibility of Cassava To Colletotrichum-gloeosporioides F Sp Manihotis

   van der Bruggen, Pierre[UCL] Grégoire, D. Maraite, Henri[UCL] (1990) Journal of Phytopathology — Vol. 130, no. 1, p. 46-58 (1990)
9. • Journal article

   • 

   Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

   Lu, Yong-Chen Parker, Linda L Lu, Tangying Zheng, Zhili Toomey, Mary Ann White, Donald E Yao, Xin Li, Yong F Robbins, Paul F Feldman, Steven A van der Bruggen, Pierre[UCL] Klebanoff, Christopher A Goff, Stephanie L Sherry, Richard M Kammula, Udai S Yang, James C Rosenberg, Steven A (2017) Journal of Clinical Oncology — Vol. 35, p. 3322-3329 (2017)
10. • Journal article

    • 

    New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells

    Kobayashi, T. Lonchay, Christophe Colau, Didier[UCL] Demotte, Nathalie[UCL] Boon, Thierry[UCL] van der Bruggen, Pierre[UCL] (2003) Tissue Antigens — Vol. 62, no. 5, p. 426-432 (2003)
11. • Speech

    • 

    Is it possible to correct the impaired function of human tumor-infiltrating T lymphocytes?

    van der Bruggen, Pierre[UCL] Demotte, Nathalie[UCL] Wieers, Grégoire[UCL] (2010) 25th Annual Meeting of the International Society for Biological Therapy of Cancer — Washington D.C., USA
12. • Journal article

    • 

    Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

    Dunbar, P R Ogg, G S Chen, J Rust, N van der Bruggen, Pierre[UCL] Cerundolo, V (1998) Current Biology — Vol. 8, no. 7, p. 413-6 (1998)
13. • BookChapter

    • 

    Human tumor antigens recognized by cytolytic T lymphocytes: Towards vaccination

    van der Bruggen, Pierre[UCL] (2000) Minor Histocompatibility Antigens: From the Laboratory to the Clinic — [ISBN : 1570595992]
14. • Speech

    • 

    Keynote Lecture: Is it possible to correct the anergy of human tumor-infiltrating lymphocytes?

    van der Bruggen, Pierre[UCL] (2009) 9th Jenner Symposium on “Glycobiology and Medicine” of the Royal Society of Medicine (UK) — Brussels, Belgium
15. • Journal article

    • 

    Database of T cell-defined human tumor antigens: the 2013 update.

    Vigneron, Nathalie[UCL] Stroobant, Vincent[UCL] Van den Eynde, Benoît[UCL] van der Bruggen, Pierre[UCL] (2013) Cancer Immunity — Vol. 13, p. 15 (2013)
16. • Speech

    • 

    Antigens recognized by T lymphocytes on human tumors

    Boon, Thierry[UCL] Van den Eynde, Benoît[UCL] van der Bruggen, Pierre[UCL] (1997) 12th International Histocompatibility Workshop & Conference — Paris, France
17. • Journal article

    • 

    A gene encoding an antigen recognized by cytolytic lymphocytes-T on a human-melanoma

    van der Bruggen, Pierre[UCL] Traversari, Catia[UCL] Chomez, Patrick[UCL] Lurquin, Christophe[UCL] De Plaen, Etienne[UCL] Van den Eynde, Benoît[UCL] Knuth, Alex Boon, Thierry[UCL] (1991) Science — Vol. 254, no. 5038, p. 1643-1647 (1991)
18. • Speech

    • 

    Invited lecture: T cell-defined tumor antigens: perspectives for cancer vaccines

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) International Symposium on Recent Advances of Human Tumor Immunology and Immunotherapy — Sapporo, Japan
19. • Speech

    • 

    Invited lecture: Tumor antigens recognized by T lymphocytes

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1997) 12th Meeting of the Society for Biological Therapy — Pasadena, USA
20. • Journal article

    • 

    Molecular definition of tumor-antigens recognized by T lymphocytes

    van der Bruggen, Pierre[UCL] Van den Eynde, Benoît[UCL] (1992) Current Opinion in Immunology — Vol. 4, no. 5, p. 608-612 (1992)
21. • Speech

    • 

    Invited lecture: Tumor antigens recognized by T cells: perspectives for cancer vaccines

    Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) 13th Annual Society for Biological Therapy Meeting — Pittsburg, USA
22. • Speech

    • 

    Invited lecture: T cell-defined tumor antigens: perspectives for cancer vaccines

    Van den Eynde, Benoît[UCL] Guéguen, M. Mandruzzato, S. van der Bruggen, Pierre[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) XIIIth Congress of the European Association of Urology — Barcelona, Spain
23. • BookChapter

    • 

    Tumour antigens recognised by T lymphocytes

    Pang, Ken C. Van den Eynde, Benoît[UCL] van der Bruggen, Pierre[UCL] Chen, Weisan (2013) eLS 2013 —
24. • Journal article

    • 

    Identification of tumor rejection antigens recognized by lymphocytes-T

    Boon, Thierry[UCL] De Plaen, Etienne[UCL] Lurquin, Christophe[UCL] Van den Eynde, Benoît[UCL] van der Bruggen, Pierre[UCL] Traversari, Catia[UCL] Amar-Costesec, Alain[UCL] Van Pel, Aline[UCL] (1992) Cancer Surveys — Vol. 13, p. 23-37 (1992)
25. • Speech

    • 

    Invited lecture: The molecular nature of T-cell defined tumor antigens

    Van den Eynde, Benoît[UCL] Chaux, Pascal[UCL] Morel, Sandra[UCL] van der Bruggen, Pierre[UCL] De Giovanni, G.[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1998) The Robert Steel Foundation International Symposium — New York, USA

Pages